Stonepine Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-509,356
| Closed | -$1.02M | – | 31 |
|
2019
Q3 | $1.02M | Buy |
+509,356
| New | +$1.02M | 0.99% | 18 |
|
2019
Q1 | – | Sell |
-424,101
| Closed | -$1.06M | – | 35 |
|
2018
Q4 | $1.06M | Sell |
424,101
-474,056
| -53% | -$1.18M | 0.93% | 17 |
|
2018
Q3 | $3.61M | Sell |
898,157
-1,031,865
| -53% | -$4.15M | 2.11% | 14 |
|
2018
Q2 | $7.3M | Sell |
1,930,022
-1,311,528
| -40% | -$4.96M | 4.43% | 8 |
|
2018
Q1 | $7.52M | Buy |
3,241,550
+45,858
| +1% | +$106K | 4.03% | 9 |
|
2017
Q4 | $4.95M | Buy |
3,195,692
+328,907
| +11% | +$510K | 2.97% | 13 |
|
2017
Q3 | $6.11M | Buy |
2,866,785
+1,271,236
| +80% | +$2.71M | 3.6% | 12 |
|
2017
Q2 | $7.21M | Sell |
1,595,549
-1,161,711
| -42% | -$5.25M | 3.89% | 12 |
|
2017
Q1 | $8.3M | Sell |
2,757,260
-401,556
| -13% | -$1.21M | 4.68% | 9 |
|
2016
Q4 | $8.72M | Buy |
3,158,816
+1,240,094
| +65% | +$3.42M | 5.19% | 8 |
|
2016
Q3 | $6.01M | Buy |
+1,918,722
| New | +$6.01M | 4.9% | 7 |
|